Lung cancer is a serious disease. Doctors often use a mix of treatments to fight it. One common approach is neoadjuvant chemoimmunotherapy. This treatment happens before surgery. It aims to shrink tumors and make them easier to remove. But how long should this treatment last? That's a big question. Right now, there's no clear answer. Different doctors might suggest ...

Neoadjuvant therapy could be a game-changer in treating liver cancer. It is a type of cancer that starts in the bile ducts inside the liver. These bile ducts are like tiny tubes that help move waste from the liver to the gut. It is often caught late and is hard to treat. Doctors are now looking at using newer treatments like immunotherapy and targeted therapy. These...

Scientists have been working on a new way to predict if patients with a type of liver cancer, called hepatocellular carcinoma (HCC), will have an early comeback of their disease after surgery. This cancer often grows beyond a certain size and number of tumors, which doctors call "beyond Milan. " The team used magnetic resonance imaging (MRI) to create a model that ca...

Immunotherapy has been making waves in the treatment of esophageal cancer, especially when used after initial chemoradiation. But what about patients with esophageal squamous cell carcinoma who've had a different combo—immunochemotherapy before surgery? Does adjuvant immunotherapy (AIT) still matter for them? That's the question researchers are trying to answer. Ima...

Did you know that how well your lung cancer shrinks after initial treatment can tell a lot about your chances of survival? This is especially true for people with a specific type of lung cancer, called resectable stage IIIA non-small cell lung cancer. Doctors have been wondering if a significant reduction in cancer size, what they call a "major pathologic response, "...